REPLAY: For those that missed today’s live webinar, you can find a replay of the broadcast here: REPLAY
Live Q&A to Follow with Our Panel of Legal Experts
Join us on Thursday, January 25, at 2:00 PM (ET)
After almost two years since it was first proposed, the SEC will be holding a meeting on Wednesday, January 24th, at 10AM, to consider changes to the current SPAC rules.
In light of that, we have assembled a panel of SPAC legal experts to break it all down and discuss the implications.
Additionally, there will be a question and answer portion of the webinar where participants will be able to submit questions to the panel in real-time.
Keep in mind that we do not yet know what the final rule will look like, but regardless of whether there are very few surprises or lots of changes, this panel of knowledge leaders will weigh in and discuss it with the SPAC community.
We hope you’ll join us!
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...